Advertisement

Effect of Duration of Anticoagulation in the Incidence of Stroke in Patients With Left-Ventricular Thrombus

Published:October 12, 2022DOI:https://doi.org/10.1016/j.amjcard.2022.09.005
      The optimal duration of anticoagulation in patients with left-ventricular thrombus (LVT) is unclear. In the present study, we aimed to analyze the effect of treatment duration (≤12 months [short-term anticoagulation, (STA)] versus >12 months [long-term anticoagulation, (LTA)]) in the incidence of stroke and other secondary outcomes (acute myocardial infarction, bleeding, and mortality). Multivariate Cox regression was used to determine the association between treatment duration and stroke, adjusted for baseline embolic risk. A total of 98 cases of LVT (age 64.3 ± 12.8 years, female 18 [18%]) were identified. Sixty-one patients (62%) received LTA. Patients receiving LTA were older than those receiving STA (66.5 ± 11.6 vs 60.7 ± 13.9 years, p = 0.029), more often had atrial fibrillation (31% vs 0%, p <0.001), and had a higher CHA2DS2-VASc score (4.3 ± 1.6 vs 3.6 ± 1.6, p = 0.046). Stroke occurred in 2 and 10 patients (3% vs 27%, p <0.001), acute myocardial infarction in 2 and 3 patients (3% vs 8%, p = 0.292), bleeding in 4 and 3 patients (7% vs 8%, p = 0.773), and mortality in 12 and 7 patients (20% vs 19%, p = 0.927) in the LTA and STA groups, respectively. In multivariate analysis, after adjusting for embolic risk, LTA was associated with decreased risk of stroke at 5 years (adjusted hazard ratio 0.16; 95% confidence interval 0.03 to 0.72, p = 0.017). In conclusion, our data suggest that prolonged anticoagulation in patients with LVT may be associated with significantly lower risk of stroke.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Maniwa N
        • Fujino M
        • Nakai M
        • Nishimura K
        • Miyamoto Y
        • Kataoka Y
        • Asaumi Y
        • Tahara Y
        • Nakanishi M
        • Anzai T
        • Kusano K
        • Akasaka T
        • Goto Y
        • Noguchi T
        • Yasuda S.
        Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarction.
        Eur Heart J. 2018; 39: 201-208
        • van Dantzig JM
        • Delemarre BJ
        • Bot H
        • Visser CA.
        Left ventricular thrombus in acute myocardial infarction.
        Eur Heart J. 1996; 17: 1640-1645
        • Robinson AA
        • Jain A
        • Gentry M
        • McNamara RL.
        Left ventricular thrombi after STEMI in the primary PCI era: a systematic review and meta-analysis.
        Int J Cardiol. 2016; 221: 554-559
        • Gianstefani S
        • Douiri A
        • Delithanasis I
        • Rogers T
        • Sen A
        • Kalra S
        • Charangwa L
        • Reiken J
        • Monaghan M
        • MacCarthy P.
        Incidence and predictors of early left ventricular thrombus after ST-elevation myocardial infarction in the contemporary era of primary percutaneous coronary intervention.
        Am J Cardiol. 2014; 113: 1111-1116
        • Mao TF
        • Bajwa A
        • Muskula P
        • Coggins TR
        • Kennedy K
        • Magalski A
        • Skolnick DG
        • Main ML.
        Incidence of left ventricular thrombus in patients with acute ST-segment elevation myocardial infarction treated with percutaneous coronary intervention.
        Am J Cardiol. 2018; 121: 27-31
        • Tikiz H
        • Balbay Y
        • Atak R
        • Terzi T
        • Genç Y
        • Kütük E.
        The effect of thrombolytic therapy on left ventricular aneurysm formation in acute myocardial infarction: relationship to successful reperfusion and vessel patency.
        Clin Cardiol. 2001; 24: 656-662
        • O'Gara PT
        • Kushner FG
        • Ascheim DD
        • Casey Jr, DE
        • Chung MK
        • Lemos JA de
        • Ettinger SM
        • Fang JC
        • Fesmire FM
        • Franklin BA
        • Granger CB
        • Krumholz HM
        • Linderbaum JA
        • Morrow DA
        • Newby LK
        • Ornato JP
        • Ou N
        • Radford MJ
        • Tamis-Holland JE
        • Tommaso CL
        • Tracy CM
        • Woo YJ
        • Zhao DX
        2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
        J Am Coll Cardiol. 2013; 61: 485-510
        • Kernan WN
        • Ovbiagele B
        • Black HR
        • Bravata DM
        • Chimowitz MI
        • Ezekowitz MD
        • Fang MC
        • Fisher M
        • Furie KL
        • Heck DV
        • Johnston SC
        • Kasner SE
        • Kittner SJ
        • Mitchell PH
        • Rich MW
        • Richardson D
        • Schwamm LH
        • Wilson JA
        American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
        Stroke. 2014; 45 (Published correction appears in Stroke 2015;46:e54): 2160-2236
        • Ibanez B
        • James S
        • Agewall S
        • Antunes MJ
        • Bucciarelli-Ducci C
        • Bueno H
        • Caforio ALP
        • Crea F
        • Goudevenos JA
        • Halvorsen S
        • Hindricks G
        • Kastrati A
        • Lenzen MJ
        • Prescott E
        • Roffi M
        • Valgimigli M
        • Varenhorst C
        • Vranckx P
        • Widimský P
        • ESC Scientific Document Group
        2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).
        Eur Heart J. 2018; 39: 119-177
        • Reeder GS
        • Lengyel M
        • Tajik AJ
        • Seward JB
        • Smith HC
        • Danielson GK.
        Mural thrombus in left ventricular aneurysm: incidence, role of angiography, and relation between anticoagulation and embolization.
        Mayo Clin Proc. 1981; 56: 77-81
        • Keeley EC
        • Hillis LD.
        Left ventricular mural thrombus after acute myocardial infarction.
        Clin Cardiol. 1996; 19: 83-86
        • Kleindorfer DO
        • Towfighi A
        • Chaturvedi S
        • Cockroft KM
        • Gutierrez J
        • Lombardi-Hill D
        • Kamel H
        • Kernan WN
        • Kittner SJ
        • Leira EC
        • Lennon O
        • Meschia JF
        • Nguyen TN
        • Pollak PM
        • Santangeli P
        • Sharrief AZ
        • Smith SC
        • Turan TN
        • Williams LS.
        2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association.
        Stroke. 2021; 52 (Published correction appears in Stroke 2021;52:e483–e484): e364-e467
        • Lip GY
        • Nieuwlaat R
        • Pisters R
        • Lane DA
        • Crijns HJ.
        Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.
        Chest. 2010; 137: 263-272
        • Nesković AN
        • Marinković J
        • Bojić M
        • Popović AD.
        Predictors of left ventricular thrombus formation and disappearance after anterior wall myocardial infarction.
        Eur Heart J. 1998; 19: 908-916
        • Lattuca B
        • Bouziri N
        • Kerneis M
        • Portal JJ
        • Zhou J
        • Hauguel-Moreau M
        • Mameri A
        • Zeitouni M
        • Guedeney P
        • Hammoudi N
        • Isnard R
        • Pousset F
        • Collet JP
        • Vicaut E
        • Montalescot G
        • Silvain J
        • ACTION Study Group
        Antithrombotic therapy for patients with left ventricular mural thrombus.
        J Am Coll Cardiol. 2020; 75: 1676-1685
        • McDonagh TA
        • Metra M
        • Adamo M
        • Gardner RS
        • Baumbach A
        • Böhm M
        • Burri H
        • Butler J
        • Čelutkienė J
        • Chioncel O
        • Cleland JGF
        • Coats AJS
        • Crespo-Leiro MG
        • Farmakis D
        • Gilard M
        • Heymans S
        • Hoes AW
        • Jaarsma T
        • Jankowska EA
        • Lainscak M
        • Lam CSP
        • Lyon AR
        • McMurray JJV
        • Mebazaa A
        • Mindham R
        • Muneretto C
        • Francesco Piepoli M
        • Price S
        • Rosano GMC
        • Ruschitzka F
        • Kathrine Skibelund A
        • ESC Scientific Document Group
        2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.
        Eur Heart J. 2021; 42: 3599-3726
        • Shavadia JS
        • Youngson E
        • Bainey KR
        • Bakal J
        • Welsh RC.
        Outcomes and prognostic impact of prophylactic oral anticoagulation in anterior ST-segment elevation myocardial infarction patients with left ventricular dysfunction.
        J Am Heart Assoc. 2017; 6e006054
        • Shokr M
        • Ahmed A
        • Abubakar H
        • Sayedahmad Z
        • Rashed A
        • Afonso L
        • Cardozo S.
        Use of direct oral anticoagulants in the treatment of left ventricular thrombi: a tertiary center experience and review of the literature.
        Clin Case Rep. 2019; 7: 135-142
        • Bahmaid RA
        • Ammar S
        • Al-Subaie S
        • Soofi MA
        • Mhish H
        • Yahia MA.
        Efficacy of direct oral anticoagulants on the resolution of left ventricular thrombus-a case series and literature review.
        JRSM Cardiovasc Dis. 2019; 82048004019839548
        • Robinson AA
        • Trankle CR
        • Eubanks G
        • Schumann C
        • Thompson P
        • Wallace RL
        • Gottiparthi S
        • Ruth B
        • Kramer CM
        • Salerno M
        • Bilchick KC
        • Deen C
        • Kontos MC
        • Dent J.
        Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi.
        JAMA Cardiol. 2020; 5: 685-692
        • Ali Z
        • Isom N
        • Dalia T
        • Sami F
        • Mahmood U
        • Shah Z
        • Gupta K.
        Direct oral anticoagulant use in left ventricular thrombus.
        Thromb J. 2020; 18: 29
        • Iqbal H
        • Straw S
        • Craven TP
        • Stirling K
        • Wheatcroft SB
        • Witte KK.
        Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus.
        ESC Heart Fail. 2020; 7: 2032-2041
        • Verma B
        • Singh A
        • Kumar M.
        Use of dabigatran for treatment of left ventricular thrombus: a tertiary care center experience.
        J Fam Med Prim Care. 2019; 8: 2656-2660
        • Tomasoni D
        • Sciatti E
        • Bonelli A
        • Vizzardi E
        • Metra M.
        Direct oral anticoagulants for the treatment of left ventricular thrombus-A new indication? A meta-summary of case reports.
        J Cardiovasc Pharmacol. 2020; 75: 530-534
        • Guddeti RR
        • Anwar M
        • Walters RW
        • Apala D
        • Pajjuru V
        • Kousa O
        • Gujjula NR
        • Alla VM
        Treatment of left ventricular thrombus with direct oral anticoagulants: a retrospective observational study.
        Am J Med. 2020; 133: 1488-1491
        • Cochran JM
        • Jia X
        • Kaczmarek J
        • Staggers KA
        • Rifai MA
        • Hamzeh IR
        • Birnbaum Y.
        Direct oral anticoagulants in the treatment of left ventricular thrombus: a retrospective, multicenter study and meta-analysis of existing data.
        J Cardiovasc Pharmacol Ther. 2021; 26: 173-178
        • Abdelnabi M
        • Saleh Y
        • Fareed A
        • Nossikof A
        • Wang L
        • Morsi M
        • Eshak N
        • Abdelkarim O
        • Badran H
        • Almaghraby A.
        Comparative study of oral anticoagulation in left ventricular thrombi (no-LVT trial).
        J Am Coll Cardiol. 2021; 77: 1590-1592
        • Weinsaft JW
        • Kim J
        • Medicherla CB
        • Ma CL
        • Codella NCF
        • Kukar N
        • Alaref S
        • Kim RJ
        • Devereux RB.
        Echocardiographic algorithm for post–myocardial infarction LV thrombus: a gatekeeper for thrombus evaluation by delayed enhancement CMR.
        JACC Cardiovasc Imaging. 2016; 9: 505-515
        • Srichai MB
        • Junor C
        • Rodriguez LL
        • Stillman AE
        • Grimm RA
        • Lieber ML
        • Weaver JA
        • Smedira NG
        • White RD.
        Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation.
        Am Heart J. 2006; 152: 75-84